deafness sensineuronal
TRANSCRIPT
-
8/7/2019 Deafness Sensineuronal
1/80
-
8/7/2019 Deafness Sensineuronal
2/80
IntroductionIntroduction
What dilemmas?What dilemmas? Increasing number and complexity of testsIncreasing number and complexity of tests
Increasing costs of medical careIncreasing costs of medical care
What do tests results mean?What do tests results mean?
At what point does cost of testing outweighAt what point does cost of testing outweigh
value of rule out diagnosis?value of rule out diagnosis? How far do we go to diagnose etiology?How far do we go to diagnose etiology?
-
8/7/2019 Deafness Sensineuronal
3/80
Finical PressuresFinical Pressures
Increasing cost of medical careIncreasing cost of medical care Third party payers pressure to contain costThird party payers pressure to contain cost
Government pressure to contain costsGovernment pressure to contain costs Patient pressure to contain costPatient pressure to contain cost
Personal Medical savings accountsPersonal Medical savings accounts
Higher deductiblesHigher deductibles Higher coHigher co--payspays
Services not coveredServices not covered
-
8/7/2019 Deafness Sensineuronal
4/80
OverviewOverview
Diagnosis of the following:Diagnosis of the following: Unilateral Childhood SNHL of unknownUnilateral Childhood SNHL of unknown
durationduration
Sudden sensorineural hearing lossSudden sensorineural hearing loss
Unilateral inner ear complaintsUnilateral inner ear complaints
-
8/7/2019 Deafness Sensineuronal
5/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Unilateral SNHL in moderate to profoundUnilateral SNHL in moderate to profoundrange correlates with:range correlates with:
Poor academic performancePoor academic performance
Increased chance of repeating a gradeIncreased chance of repeating a grade
Behavioral problemsBehavioral problems
Intervention prior to 6 months results inIntervention prior to 6 months results inadvantages in communicationadvantages in communication
-
8/7/2019 Deafness Sensineuronal
6/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Universal infant screening has led to earlierUniversal infant screening has led to earlierdiagnosisdiagnosis
Congenital hearing loss may be delayedCongenital hearing loss may be delayed Joint Committee on Infant Hearing guidelines forJoint Committee on Infant Hearing guidelines forpersistent periodic screening:persistent periodic screening: Child with family history of early onset SNHLChild with family history of early onset SNHL
Prenatal infection that may lead to SNHLPrenatal infection that may lead to SNHL Neurofibromatosis IINeurofibromatosis II
Persistent pulmonary hypertensionPersistent pulmonary hypertension
-
8/7/2019 Deafness Sensineuronal
7/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
EpidemiologyEpidemiology Average age of diagnosis unilateral SNHL isAverage age of diagnosis unilateral SNHL is
8.7 yo.8.7 yo.
Bilateral SNHL grater than 50dB, 1Bilateral SNHL grater than 50dB, 1--2/10002/1000
Unilateral SNHL greater than 50 dB, 3/1000Unilateral SNHL greater than 50 dB, 3/1000
Genetic cause in 50% of individualsGenetic cause in 50% of individuals
-
8/7/2019 Deafness Sensineuronal
8/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Initial referral because of failedInitial referral because of failedaudiogram, parental concerns.audiogram, parental concerns.
Confirmed with audiogram, OAE, ABRConfirmed with audiogram, OAE, ABR In younger children, otolaryngologist mustIn younger children, otolaryngologist must
screen for conductive etiologyscreen for conductive etiology
-
8/7/2019 Deafness Sensineuronal
9/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Differential diagnosisDifferential diagnosis Syndrome with hearing lossSyndrome with hearing loss
Other genetic causeOther genetic cause MeningitisMeningitis
Intrauterine infectionIntrauterine infection
Trauma to cochlea, vestibule, VIIITrauma to cochlea, vestibule, VIII
Exposure to ototoxic drugExposure to ototoxic drug PrematurityPrematurity
Autoimmune diseaseAutoimmune disease
-
8/7/2019 Deafness Sensineuronal
10/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Differential DiagnosisDifferential Diagnosis HyperbilirubinemiaHyperbilirubinemia
Neurofibromatosis type IINeurofibromatosis type II Anoxic Brain injuryAnoxic Brain injury
MumpsMumps
Neurodegenerative disorderNeurodegenerative disorder
Malignant infiltrationMalignant infiltration Ischemic insult of cochleaIschemic insult of cochlea
Cochlear hydropsCochlear hydrops
-
8/7/2019 Deafness Sensineuronal
11/80
-
8/7/2019 Deafness Sensineuronal
12/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Usher syndromeUsher syndrome Autosomal recessive disorderAutosomal recessive disorder
Retinitis pigmentosa and SNHLRetinitis pigmentosa and SNHL
Early intervention for future visual andEarly intervention for future visual andauditory impairmentauditory impairment
Bilateral cochlear implant should beBilateral cochlear implant should beconsideredconsidered
-
8/7/2019 Deafness Sensineuronal
13/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Waardenburg syndromeWaardenburg syndrome SNHLSNHL
White forelockWhite forelock
Multicolored iriesMulticolored iries
Dystropia canthorumDystropia canthorum
hypertelorismhypertelorism
-
8/7/2019 Deafness Sensineuronal
14/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Jervell and LangeJervell and Lange--NielsenNielsen Autosomal dominantAutosomal dominant
Seen in 1.6 to 6 per millionSeen in 1.6 to 6 per million
Prolonged QT interval and increased risk ofProlonged QT interval and increased risk ofsudden deathsudden death
First degree relatives need screening withFirst degree relatives need screening withEKGEKG
-
8/7/2019 Deafness Sensineuronal
15/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Neurofibromatosis Type IINeurofibromatosis Type II Autosomal dominantAutosomal dominant
Bilateral acoustic neuromasBilateral acoustic neuromas
MeningiomasMeningiomas
Spinal schwannomasSpinal schwannomas
Posterior capsular lens opacitiesPosterior capsular lens opacities
-
8/7/2019 Deafness Sensineuronal
16/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Alports syndromeAlports syndrome Autosomal dominant or recessive, or xAutosomal dominant or recessive, or x--linkedlinked
Slowly progressive bilateral SNHL, can beSlowly progressive bilateral SNHL, can beasymmetricalasymmetrical
Progressive renal failureProgressive renal failure
Persistent microscopic hematuriaPersistent microscopic hematuria Episodic gross hematuria precipitated by URIEpisodic gross hematuria precipitated by URI
-
8/7/2019 Deafness Sensineuronal
17/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
BranchioBranchio--otooto--renal syndromerenal syndrome 1/40,000 live births1/40,000 live births
60% with branchial cleft cysts60% with branchial cleft cysts
20% with pure SNHL, majority mixed20% with pure SNHL, majority mixed
Shared antigen between the stria vascuularisShared antigen between the stria vascuularis
and glomeruliand glomeruli
-
8/7/2019 Deafness Sensineuronal
18/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Noonans syndromeNoonans syndrome 1/2500 live births1/2500 live births
Webbed neckWebbed neck
Pinna abnormalitiesPinna abnormalities
Short statureShort stature
1010--15% with SNHL15% with SNHL
-
8/7/2019 Deafness Sensineuronal
19/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
CHARGE SyndromeCHARGE Syndrome ColobomaColoboma
Heart DefectsHeart Defects Atresia choanaeAtresia choanae
Retarded growthRetarded growth
Genital hypoplasiaGenital hypoplasia
Ear abnormalities and deafnessEar abnormalities and deafness
Associated with Mondini malformationAssociated with Mondini malformation
-
8/7/2019 Deafness Sensineuronal
20/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Fechners syndromeFechners syndrome High frequency SNHLHigh frequency SNHL
ProteinuriaProteinuria
MacrothrombocytopeniaMacrothrombocytopenia
Ocular diseaseOcular disease
Extremely rareExtremely rare
-
8/7/2019 Deafness Sensineuronal
21/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Pendred syndromePendred syndrome Autosomal recessiveAutosomal recessive
Congenital SNHLCongenital SNHL
GoiterGoiter
Hypothyroidism (varies)Hypothyroidism (varies)
Abnormal perchlorate discharge testAbnormal perchlorate discharge test Associated with Mondini and Large VestibularAssociated with Mondini and Large Vestibular
aqueductaqueduct
-
8/7/2019 Deafness Sensineuronal
22/80
Unilateral Childhood SNHLUnilateral Childhood SNHL
Other causesOther causes TORCHS (Toxoplasmosis, Others, Rubella,TORCHS (Toxoplasmosis, Others, Rubella,
Cytomegalovirus, Herpes simplex, Syphilis)Cytomegalovirus, Herpes simplex, Syphilis) MeningitisMeningitis
Ototoxic drug exposureOtotoxic drug exposure
Maternal drug alcohol useMaternal drug alcohol use Maternal use of teratogenic drugMaternal use of teratogenic drug
(thalidomide)(thalidomide)
-
8/7/2019 Deafness Sensineuronal
23/80
Diagnostic TestingDiagnostic Testing
CBC with DifferentialCBC with Differential Platelet studiesPlatelet studies ANA, ESR, RFANA, ESR, RF BUN, Creatinine, UrinalysisBUN, Creatinine, Urinalysis Serum glucoseSerum glucose Thyroid function tests, Perchlorate testThyroid function tests, Perchlorate test RPR, TTPARPR, TTPA
GJB2 (Connexin 26)GJB2 (Connexin 26) EKGEKG CT, MRICT, MRI
-
8/7/2019 Deafness Sensineuronal
24/80
Diagnostic TestingDiagnostic Testing
CBC with differentialCBC with differential Used to screen for leukemia or lymphomaUsed to screen for leukemia or lymphoma
Hearing loss due to hyperviscosity or temporalHearing loss due to hyperviscosity or temporalbone infiltrationbone infiltration
1 case of leukemia with hearing loss as initial1 case of leukemia with hearing loss as initial
manifestation in literaturemanifestation in literature Low yieldLow yield
-
8/7/2019 Deafness Sensineuronal
25/80
Diagnostic TestingDiagnostic Testing
Platelet studiesPlatelet studies Drawn to exclude Fechner syndromeDrawn to exclude Fechner syndrome
Patients with family history, ocular disease,Patients with family history, ocular disease,history of diagnosed proteinuria should behistory of diagnosed proteinuria should bescreenedscreened
Test is low yieldTest is low yield
-
8/7/2019 Deafness Sensineuronal
26/80
Diagnostic TestingDiagnostic Testing
ANA, ESR, RFANA, ESR, RF Drawn to screen for autoimmune disorders,Drawn to screen for autoimmune disorders,
Lupus, Cogan's, juvenile rheumatoid arthritisLupus, Cogan's, juvenile rheumatoid arthritis Test nonspecificTest nonspecific
Positive RF is 0.7% sensitive in detectingPositive RF is 0.7% sensitive in detectingjuvenile RAjuvenile RA
Testing without history of joint pain or otherTesting without history of joint pain or othersigns of systemic autoimmune disorders is lowsigns of systemic autoimmune disorders is lowyieldyield
-
8/7/2019 Deafness Sensineuronal
27/80
Diagnostic TestingDiagnostic Testing
BUN, Creatinine, UrinalysisBUN, Creatinine, Urinalysis Used to screen for concurrent kidney diseaseUsed to screen for concurrent kidney disease
such as Alports diseasesuch as Alports disease Should be drawn with history of grossShould be drawn with history of gross
hematuria, family history of kidney disease,hematuria, family history of kidney disease,family history of slowly progressive hearingfamily history of slowly progressive hearinglossloss
Routine screening is low yieldRoutine screening is low yield
-
8/7/2019 Deafness Sensineuronal
28/80
Diagnostic TestingDiagnostic Testing
Serum glucoseSerum glucose Used to screen for Alston syndrome (ImpairedUsed to screen for Alston syndrome (Impaired
glucose tolerance, retinal degeneration,glucose tolerance, retinal degeneration,neurosensory deafness, acanthosis nigricans,neurosensory deafness, acanthosis nigricans,hepatic dysfunction)hepatic dysfunction)
Only 50 cases reported since 1959Only 50 cases reported since 1959
Very low yieldVery low yield
-
8/7/2019 Deafness Sensineuronal
29/80
-
8/7/2019 Deafness Sensineuronal
30/80
Diagnostic TestingDiagnostic Testing
RPR, TTPARPR, TTPA Drawn to look for syphilis.Drawn to look for syphilis.
Hearing loss with tertiary syphilis usuallyHearing loss with tertiary syphilis usuallyassociated with other manifestations of theassociated with other manifestations of thedisease, but can be sole manifestationdisease, but can be sole manifestation
History of maternal syphilis exposure, signs ofHistory of maternal syphilis exposure, signs oftertiary syphilis make testing higher yieldtertiary syphilis make testing higher yield
Testing low yieldTesting low yield
-
8/7/2019 Deafness Sensineuronal
31/80
-
8/7/2019 Deafness Sensineuronal
32/80
Diagnostic TestingDiagnostic Testing
GJB2 gene (Connexin 26)GJB2 gene (Connexin 26) Responsible for as much as 50% of autosomalResponsible for as much as 50% of autosomal
recessive nonsyndromic hearing lossrecessive nonsyndromic hearing loss Use most important in genetic counseling forUse most important in genetic counseling for
parents of hearing impaired childrenparents of hearing impaired children
Homozygous children have a 25% chance ofHomozygous children have a 25% chance of
having siblings with hearing loss. Negative orhaving siblings with hearing loss. Negative orheterozygous results gives siblings 14%heterozygous results gives siblings 14%chancechance
-
8/7/2019 Deafness Sensineuronal
33/80
Diagnostic TestingDiagnostic Testing
CT and MRICT and MRI Used to scan for inner ear malformationsUsed to scan for inner ear malformations
Mondini malformation associated withMondini malformation associated withperilymphatic fistulas and recurrent meningitisperilymphatic fistulas and recurrent meningitis
Large vestibular aqueduct associated withLarge vestibular aqueduct associated withhearing loss as a result of minor head traumahearing loss as a result of minor head trauma
MRI used for screening for acoustic neuromaMRI used for screening for acoustic neuromain children with neurofibromatosis type IIin children with neurofibromatosis type II
-
8/7/2019 Deafness Sensineuronal
34/80
-
8/7/2019 Deafness Sensineuronal
35/80
-
8/7/2019 Deafness Sensineuronal
36/80
-
8/7/2019 Deafness Sensineuronal
37/80
-
8/7/2019 Deafness Sensineuronal
38/80
-
8/7/2019 Deafness Sensineuronal
39/80
-
8/7/2019 Deafness Sensineuronal
40/80
-
8/7/2019 Deafness Sensineuronal
41/80
-
8/7/2019 Deafness Sensineuronal
42/80
Mafong et al, Laryngoscope 2002Mafong et al, Laryngoscope 2002
EKG positive in 1 of 15 patients tested.EKG positive in 1 of 15 patients tested. ESR and ANA were positive in 22% ofESR and ANA were positive in 22% of
patients. No correlation with clinicalpatients. No correlation with clinicaldisease. Occasional nonspecificdisease. Occasional nonspecificabnormalities in CBC.abnormalities in CBC.
All other laboratory testing negative.All other laboratory testing negative.
-
8/7/2019 Deafness Sensineuronal
43/80
Mafong et al, Laryngoscope 2002Mafong et al, Laryngoscope 2002
CT scanCT scan 39% with abnormality39% with abnormality
Large vestibular aqueduct in 13%Large vestibular aqueduct in 13%
Cochlear dysplasia in 7%Cochlear dysplasia in 7%
MRI added to diagnosis in 4, one of whichMRI added to diagnosis in 4, one of which
related to hearing loss (fistulous connectionrelated to hearing loss (fistulous connectionfrom IAC to temporal bone)from IAC to temporal bone)
-
8/7/2019 Deafness Sensineuronal
44/80
Mafong et al, Laryngoscope 2002Mafong et al, Laryngoscope 2002
Authors concluded that routine laboratoryAuthors concluded that routine laboratoryevaluation should be reconsidered givenevaluation should be reconsidered given
its low diagnostic yieldits low diagnostic yield They supported routine use of EKG and CTThey supported routine use of EKG and CT
scan.scan.
-
8/7/2019 Deafness Sensineuronal
45/80
ConclusionsConclusions
EKGEKG sudden childhood deathsudden childhood death CTCT High incidence of abnormalityHigh incidence of abnormality
Large vestibular aqueductLarge vestibular aqueduct avoid contactavoid contactsportssports
Used for preoperative information shouldUsed for preoperative information should
bilateral SNHL developbilateral SNHL develop Mondini malformation lead to further testingMondini malformation lead to further testing
-
8/7/2019 Deafness Sensineuronal
46/80
ConclusionConclusion
SyphilisSyphilis Rare without classical stigmata (interstitialRare without classical stigmata (interstitial
keratitis, Hutchinsons teeth, mulberry molars,keratitis, Hutchinsons teeth, mulberry molars,bilateral painless knee effusions, nasal septalbilateral painless knee effusions, nasal septalperforation, saddle nose deformity)perforation, saddle nose deformity)
Simple treatment, potentially fatalSimple treatment, potentially fatal
Recommend testing with RPR, confirmationRecommend testing with RPR, confirmationwith TTPAwith TTPA
-
8/7/2019 Deafness Sensineuronal
47/80
ConclusionConclusion
GJB2 (Connexin 26)GJB2 (Connexin 26) Screening only if result will affect futureScreening only if result will affect future
childhood planningchildhood planning Genetics consult warranted for counseling ofGenetics consult warranted for counseling of
resultsresults
-
8/7/2019 Deafness Sensineuronal
48/80
ConclusionConclusion
-- Fever or illness more than 3 weeks,Fever or illness more than 3 weeks,gingival bleeding, bone or joint pain, signsgingival bleeding, bone or joint pain, signs
of autoimmune disease, order CBC andof autoimmune disease, order CBC andANA, ESR, RFANA, ESR, RF
-- Family history of progressive early onsetFamily history of progressive early onset
hearing loss in first or second degreehearing loss in first or second degreerelative, order urinalysis, genetics consultrelative, order urinalysis, genetics consult
-
8/7/2019 Deafness Sensineuronal
49/80
ConclusionConclusion
Family history of progressive vision loss or visualFamily history of progressive vision loss or visualcomplaints, order ophthalmology consultcomplaints, order ophthalmology consult
History of hematuria or family history of kidneyHistory of hematuria or family history of kidneyfailure, order urinalysis. If urinalysis positivefailure, order urinalysis. If urinalysis positiveorder BUN, creatinineorder BUN, creatinine
Thyroid goiter, signs of hypothyroidism, MondiniThyroid goiter, signs of hypothyroidism, Mondini
malformation, large vestibular aqueduct by CTmalformation, large vestibular aqueduct by CTscan, order thyroid function test, considerscan, order thyroid function test, considerperchlorate testperchlorate test
-
8/7/2019 Deafness Sensineuronal
50/80
ConclusionConclusion
History of frequent urination, excessive thirst,History of frequent urination, excessive thirst,order serum glucoseorder serum glucose
History of progressive hearing loss, gait orHistory of progressive hearing loss, gait orvestibular symptoms, focal neurologicalvestibular symptoms, focal neurologicalsymptoms, order MRI of brain and IACssymptoms, order MRI of brain and IACs
History of neurofibroma, meningioma, glioma,History of neurofibroma, meningioma, glioma,schwannoma, juvenile posterior subcapsularschwannoma, juvenile posterior subcapsularlenticular opacity or family history oflenticular opacity or family history ofNeurofibromatosis type II, order MRI of brainNeurofibromatosis type II, order MRI of brainand IACs.and IACs.
-
8/7/2019 Deafness Sensineuronal
51/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Incidence estimated between 5 and 20 perIncidence estimated between 5 and 20 per100,000100,000
Most common between ages of 40 and 54Most common between ages of 40 and 54 Loss of at least 30dB in 3 contiguousLoss of at least 30dB in 3 contiguous
frequencies in 72 hours or lessfrequencies in 72 hours or less
65% diagnosed will spontaneously recover65% diagnosed will spontaneously recoverwithin 20dB or greater than 50% of totalwithin 20dB or greater than 50% of totallossloss
-
8/7/2019 Deafness Sensineuronal
52/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
EtiologyEtiology Vascular compromise from hyperviscosity, embolicVascular compromise from hyperviscosity, embolic
event, vasospasm.event, vasospasm.
Intracochlear membrane rupture or perilymph fistulasIntracochlear membrane rupture or perilymph fistulas
Viral infectionViral infection
Autoimmune inner ear disease, systemic autoimmuneAutoimmune inner ear disease, systemic autoimmunedisease (Cogans, Wegners, polyarteritis nodosa,disease (Cogans, Wegners, polyarteritis nodosa,temporal arteritis, Berger's, SLE)temporal arteritis, Berger's, SLE)
-
8/7/2019 Deafness Sensineuronal
53/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Diagnostic testingDiagnostic testing CBCCBC
ESR, ANA, RFESR, ANA, RF Serum GlucoseSerum Glucose
T3, T4, TSHT3, T4, TSH
PT, PTTPT, PTT RPR, TTPARPR, TTPA
-
8/7/2019 Deafness Sensineuronal
54/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Diagnostic testingDiagnostic testing HIVHIV
Lyme titerLyme titer Cholesterol/TriglyceridesCholesterol/Triglycerides
AntiAnti--hsp 70 (68KD heat shock protein)hsp 70 (68KD heat shock protein)
MRIMRI
-
8/7/2019 Deafness Sensineuronal
55/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
CBCCBC ESR, ANA, RFESR, ANA, RF
Serum GlucoseSerum Glucose Thyroid function studiesThyroid function studies RPR, TTPARPR, TTPA
-
8/7/2019 Deafness Sensineuronal
56/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
PT, PTTPT, PTT Used to look for hemorrhagic etiology ofUsed to look for hemorrhagic etiology of
SSNHLSSNHL Patients likely to have other manifestations ofPatients likely to have other manifestations of
coagulopathycoagulopathy
Higher yield if patient currently on anHigher yield if patient currently on ananticoagulantanticoagulant
-
8/7/2019 Deafness Sensineuronal
57/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
HIVHIV Shown to decrease hearing in up to 30% ofShown to decrease hearing in up to 30% of
patients with active infection compared topatients with active infection compared tocontrols.controls.
Literature shows 3 cases of SSNHL withLiterature shows 3 cases of SSNHL withpositive HIVpositive HIV
Low yieldLow yield
HIV treatment early improves life expectancyHIV treatment early improves life expectancy
-
8/7/2019 Deafness Sensineuronal
58/80
-
8/7/2019 Deafness Sensineuronal
59/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Gagnebin 2000 (French study)Gagnebin 2000 (French study) Analyzed screening HIV, Lyme, syphilisAnalyzed screening HIV, Lyme, syphilis
102 charts reviewed102 charts reviewed Two patients with positive Lyme titers, notTwo patients with positive Lyme titers, not
responding to treatmentresponding to treatment
All HIV negativeAll HIV negative
Latent syphilis without signs of neurosyphilis in oneLatent syphilis without signs of neurosyphilis in onepatientpatient
Concluded screening is low yield without historyConcluded screening is low yield without history
-
8/7/2019 Deafness Sensineuronal
60/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
AntiAnti--hsp70 (68KD heat shock protein)hsp70 (68KD heat shock protein) Thought to be a marker of autoimmune inner earThought to be a marker of autoimmune inner ear
etiologyetiology
Early studies have shown steroid responsiveness inEarly studies have shown steroid responsiveness inpatients with positive testspatients with positive tests
Samuelsson screened 27 with SSNHL and 100Samuelsson screened 27 with SSNHL and 100controls. 19% and 14% respectively (not significant)controls. 19% and 14% respectively (not significant)
Yeom in 2003 tested for antiYeom in 2003 tested for anti--hsp 70 in 20 patientshsp 70 in 20 patientswith rapidly progressive SNHL and 20 controls. Nowith rapidly progressive SNHL and 20 controls. Nosignificant differencesignificant difference
-
8/7/2019 Deafness Sensineuronal
61/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
AntiAnti--hsp70 (68KD heat shock protein)hsp70 (68KD heat shock protein) Testing is high yieldTesting is high yield
Question as to validity of resultsQuestion as to validity of results Question of utility of positive resultsQuestion of utility of positive results
(most patients treated with steroids)(most patients treated with steroids)
-
8/7/2019 Deafness Sensineuronal
62/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Cholesterol and TriglyceridesCholesterol and Triglycerides Labyrinthine artery atherosclerosis as anLabyrinthine artery atherosclerosis as an
etiologyetiology FriedrichFriedrich 49 patients with neurootologic49 patients with neurootologic
symptoms. Increased LDL and LDL/HDL ratiosymptoms. Increased LDL and LDL/HDL ratioas compared to controlsas compared to controls
NutiNuti No significant difference in cholesterolNo significant difference in cholesteroland LDL/HDL ratio with controlsand LDL/HDL ratio with controls
-
8/7/2019 Deafness Sensineuronal
63/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Cholesterol and TriglyceridesCholesterol and Triglycerides UllrichUllrich tested lipids and triglycerides in 24tested lipids and triglycerides in 24
patients with SSNHL. No significant differencepatients with SSNHL. No significant differencefrom controlsfrom controls
KojimaKojima 12 patients with SSNHL12 patients with SSNHL Event was at least 1 month prior studyEvent was at least 1 month prior study
Patients with total cholesterol greater thanPatients with total cholesterol greater than230mg/dL treated with diet and medications230mg/dL treated with diet and medications Significant improvement in 125Significant improvement in 125--2000 Hz2000 Hz
-
8/7/2019 Deafness Sensineuronal
64/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
Cholesterol and TriglyceridesCholesterol and Triglycerides American College of Physicians recommendsAmerican College of Physicians recommends
screening for lipid abnormalities in men 35screening for lipid abnormalities in men 35--6565and women 45and women 45--65 years of age using total65 years of age using totalcholesterol level only.cholesterol level only.
Cholesterol or triglyceride levels as an etiologyCholesterol or triglyceride levels as an etiology
of SSNHL likely low probabilityof SSNHL likely low probability Testing in this age range is high yieldTesting in this age range is high yield
-
8/7/2019 Deafness Sensineuronal
65/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
MRIMRI Used to screen for acoustic neuromaUsed to screen for acoustic neuroma
Patients with acoustic neuroma present withPatients with acoustic neuroma present withSSNHL 10% of the timeSSNHL 10% of the time
As high as 2.5% of all patients with SSNHLAs high as 2.5% of all patients with SSNHLhave an acoustic neuromahave an acoustic neuroma
-
8/7/2019 Deafness Sensineuronal
66/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
MRIMRI Able to screen for acoustic neuroma and otherAble to screen for acoustic neuroma and other
causes of hearing losscauses of hearing loss AronzonAronzon treated patients with SSNHL andtreated patients with SSNHL andMRI proven acoustic neuroma with high doseMRI proven acoustic neuroma with high doseof steroidsof steroids Improvement in hearing of all patientsImprovement in hearing of all patients Response to steroids does not exclude acousticResponse to steroids does not exclude acoustic
neuromaneuroma
-
8/7/2019 Deafness Sensineuronal
67/80
ConclusionsConclusions
All patients should be screened with RPR,All patients should be screened with RPR,confirmed with TTPA (treatable, lifeconfirmed with TTPA (treatable, life
threatening, low cost)threatening, low cost) MRI in all patients, regardless of responseMRI in all patients, regardless of responseto steroidsto steroids
Total cholesterol in men aged 35Total cholesterol in men aged 35--65,65,women aged 45women aged 45--65 if no testing in the last65 if no testing in the lastyearyear
-
8/7/2019 Deafness Sensineuronal
68/80
ConclusionsConclusions
HIV testing in all patients with high risk ofHIV testing in all patients with high risk ofSTD, +/STD, +/-- in all patientsin all patients
ESR, ANA, RF in patients with history andESR, ANA, RF in patients with history andphysical findings of autoimmune etiology,physical findings of autoimmune etiology,response to steroid, but relapse afterresponse to steroid, but relapse after
tapertaper
-
8/7/2019 Deafness Sensineuronal
69/80
Sudden Sensorineural Hearing LossSudden Sensorineural Hearing Loss
CBC, Thyroid function tests, PT, PTT,CBC, Thyroid function tests, PT, PTT,Lyme titers based on history or physicalLyme titers based on history or physical
exam findings onlyexam findings only 68 KD protein in research settings, +/68 KD protein in research settings, +/-- inin
response to steroids with relapse afterresponse to steroids with relapse after
steroid tapersteroid taper
-
8/7/2019 Deafness Sensineuronal
70/80
Acoustic NeuromaAcoustic Neuroma
12 per million per year12 per million per year MRI can detect tumors as small as 3mmMRI can detect tumors as small as 3mm
Gold standard for diagnosis is MRI ofIACsGold standard for diagnosis is MRI ofIACswith gadoliniumwith gadolinium
Test cost at this institution is $3200Test cost at this institution is $3200
-
8/7/2019 Deafness Sensineuronal
71/80
Acoustic NeuromaAcoustic Neuroma
ABRABR Alternative to MRI for diagnosisAlternative to MRI for diagnosis
MRI generally 5 times more expensive thanMRI generally 5 times more expensive thanABRABR
Decreased sensitivityDecreased sensitivity
Cost at this institution is $500Cost at this institution is $500
-
8/7/2019 Deafness Sensineuronal
72/80
Acoustic NeuromaAcoustic Neuroma
Sensitivity of ABRSensitivity of ABR Wilson 1992Wilson 1992 sensitivity of 85%, 67% forsensitivity of 85%, 67% for
small tumorssmall tumors Chandrasekhar 1995Chandrasekhar 1995 sensitivity of 92%,sensitivity of 92%,83% for small tumors83% for small tumors
Gordon 1995Gordon 1995 sensitivity 88%, 69% for smallsensitivity 88%, 69% for small
tumorstumors Ruckershern 1996Ruckershern 1996 sensitivity of 63%, PPVsensitivity of 63%, PPV26%26%
-
8/7/2019 Deafness Sensineuronal
73/80
Acoustic NeuromaAcoustic Neuroma
Robinette and BauchRobinette and Bauch Retrospective review to identify 95 patients withRetrospective review to identify 95 patients with
acoustic neuromasacoustic neuromas
Divided into 3 groupsDivided into 3 groups
High riskHigh risk asymmetric hearing loss of greater than 20 DBasymmetric hearing loss of greater than 20 DBover three frequencies, greater than 30% decrease of wordover three frequencies, greater than 30% decrease of wordrecognitionrecognition
Intermediate riskIntermediate risk SSNHL or unexplained persistentSSNHL or unexplained persistentunilateral tinnitusunilateral tinnitus
Low riskLow risk isolated vertigo or historically explainedisolated vertigo or historically explainedintermittent tinnitus or historically explained SNHLintermittent tinnitus or historically explained SNHL
-
8/7/2019 Deafness Sensineuronal
74/80
Acoustic NeuromaAcoustic Neuroma
Used probability of acoustic in each groupUsed probability of acoustic in each groupas (30%, 5%, 1%)as (30%, 5%, 1%)
Sensitivity of detecting tumors with ABRSensitivity of detecting tumors with ABRbased on size (100% large, 93% medium,based on size (100% large, 93% medium,82% small)82% small)
Used PPV of 12% in ABRUsed PPV of 12% in ABR
-
8/7/2019 Deafness Sensineuronal
75/80
Acoustic NeuromaAcoustic Neuroma
Calculated cost of MRI for patients in eachCalculated cost of MRI for patients in eachgroupgroup
Calculated cost of ABR, and MRI for allCalculated cost of ABR, and MRI for allABRs suggestive of acoustic neuromaABRs suggestive of acoustic neuroma Calculated cost difference of two groupsCalculated cost difference of two groups
based on risk from history and physicalbased on risk from history and physical
Calculated number acoustic neuromasCalculated number acoustic neuromasmissed if first screened with ABRmissed if first screened with ABR
-
8/7/2019 Deafness Sensineuronal
76/80
Acoustic NeuromaAcoustic Neuroma
High riskHigh risk -- $40,000, no missed tumors$40,000, no missed tumors Intermediate riskIntermediate risk -- $900,000, clinician would$900,000, clinician would
miss 4 tumors in 900 patients screenedmiss 4 tumors in 900 patients screened Low riskLow risk $1.7 million, 1 tumor missed out of$1.7 million, 1 tumor missed out of
1600 screened1600 screened
Authors recommended clinical decision makingAuthors recommended clinical decision makingwith consideration of cost savings inwith consideration of cost savings inintermediate to low risk groupsintermediate to low risk groups
-
8/7/2019 Deafness Sensineuronal
77/80
ConclusionConclusion
MRI in:MRI in: All patients with unilateral SNHL greater thanAll patients with unilateral SNHL greater than
20dB difference from unaffected side not20dB difference from unaffected side notexplained by historyexplained by history
Word discrimination difference of 30% orWord discrimination difference of 30% orgreater from asymptomatic sidegreater from asymptomatic side
-
8/7/2019 Deafness Sensineuronal
78/80
ConclusionConclusion
MRIMRI Unilateral persistent tinnitus not explained byUnilateral persistent tinnitus not explained by
historyhistory Persistent vertigoPersistent vertigo
Unilateral sudden SNHL, regardless ofUnilateral sudden SNHL, regardless ofresponse to steroidsresponse to steroids
-
8/7/2019 Deafness Sensineuronal
79/80
ConclusionsConclusions
ABR vs. MRIABR vs. MRI Historically explained unilateral tinnitusHistorically explained unilateral tinnitus
Historically explained hearing lossHistorically explained hearing loss Isolated vertigoIsolated vertigo
-
8/7/2019 Deafness Sensineuronal
80/80
SummarySummary
Number of diagnostic tests expandingNumber of diagnostic tests expanding Physicians asked more and more toPhysicians asked more and more to
evaluate medical necessity and costevaluate medical necessity and costbenefit of diagnostic testingbenefit of diagnostic testing
Research projects based on cost analysisResearch projects based on cost analysis
Balance of cost containment andBalance of cost containment anddiagnostic accuracydiagnostic accuracy